Investor Presentation First Nine Months of 2023

119 Investor presentation First nine months of 2023 Diabetes market share and market growth in EMEA 75% 50% 25% Diabetes market growth and Novo Nordisk market share 0% Aug 2020 EMEA DKK billion Diabetes market size and growth ~13% 20% 18% 4 125 6 6 111 13% 15% 38% 10% 30% 5% 29% 0% Aug 2023 Aug NN 2022 ~18% 30% Company A Others Aug 2023 Novo Nordisk Competitors NN market share -Market growth (right axis) NN share of growth NN growth (right axis) Source: IQVIA, Aug 2023, Value, MAT; Due to contractual obligations competitor names are not disclosed. Company A represents an actual company. EMEA: Europe, Middle East and Africa; NN: Novo Nordisk; Market values are based on the list prices

View entire presentation